Tackling Barriers to Migraine Care
Episode 46, Sep 10, 2021, 10:00 AM
Welcome to the NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with Deena Kuruvilla, MD, director, Westport Headache Institute, who spoke to the current state of affairs in the clinical care of migraine. She also shared her insight into the issues that specialists need to overcome, such as access to therapy, the real-world use of novel treatments for headache disorders, and the advances that are currently in the research and development stage.
Episode Breakdown:
In this episode, we spoke with Deena Kuruvilla, MD, director, Westport Headache Institute, who spoke to the current state of affairs in the clinical care of migraine. She also shared her insight into the issues that specialists need to overcome, such as access to therapy, the real-world use of novel treatments for headache disorders, and the advances that are currently in the research and development stage.
Episode Breakdown:
- 1:25 – Trends in the clinical care of migraine over the last year
- 5:00 –The effect of the COVID-19 pandemic on patients with migraine
- 7:05 – Ongoing barriers of access to migraine treatments
- 9:20 – Neurology News Minute
- 13:25 –Addressing the need for more migraine specialists
- 15:55 –Real-world use of available migraine therapies and devices
- 17:20 – Recent introductions to the physician's migraine toolkit
- 20:40 – Lingering therapeutic needs in migraine and the role of advocacy in improving care
The stories featured in this week's Neurology News Minute are further detailed here:
- FDA Approves Vivistim VNS System for Ischemic Stroke Motor Deficits
- FDA Approves Brivaracetam for Partial-Onset Seizures in Pediatric Epilepsy
- Acute Migraine Treatment INP104 Approved
Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.